Krishna Institute of Medical Sciences balance sheet

As of Mar 2026

Total assets: ₹7,759cr+35.3% on Mar 2025
Shareholders' equity: ₹2,559cr+5.8% on Mar 2025
Total debt: ₹3,244cr+26.9% on Mar 2025
Cash and investments: ₹70.5cr−9.6% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	4,186	2,199	1,730	1,381
	606	1,214	600	477
	339	339	308	308
	57.0	811	64.6	77.7
	0.0	0.0	331	0.0
	0.0	76.5	0.0	0.0
	0.6	0.6	74.4	0.0
	13.4	5.5	26.0	0.0
	1,294	60.1	92.7	56.7
	1,308	66.2	193	56.7
	127	104	31.9	64.0
	198	230	0.0	99.8
	6,821	5,039	3,259	2,464
	96.9	64.0	49.4	42.9
	15.1	22.0	83.0	67.9
	554	395	294	253
	55.4	56.0	46.9	61.6
	19.3	23.7	2.1	4.8
	72.2	47.7	0.0	0.0
	67.5	50.8	35.8	36.4
	784	596	462	423
	56.8	37.7	35.8	11.5
	937	697	593	478
	7,759	5,736	3,852	2,941
Equity
	80.0	80.0	80.0	80.0
	2,167	2,058	1,748	1,590
	2,247	2,138	1,828	1,670
	311	281	265	268
	2,559	2,419	2,093	1,938
Liabilities
	2,673	2,287	1,226	634
	1,175	77.8	6.5	0.4
	3,848	2,365	1,233	634
	45.7	33.5	27.4	23.6
	68.0	46.8	46.3	49.2
	60.8	35.7	0.0	0.0
	3,961	2,481	1,306	707
	571	270	129	44.6
	323	269	197	174
	234	216	61.1	30.5
	1,128	754	387	249
	32.6	26.4	18.6	14.1
	0.0	1.6	0.0	0.0
	78.0	53.8	46.4	33.1
	1,239	836	452	296
	5,200	3,317	1,759	1,003
	7,759	5,736	3,852	2,941
Assets — additional as-filed lines
	0.0	0.0	45.5	0.0
Trade payables — MSME split
	53.4	15.0	—	—
	269	254	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

KIMS₹702.50

Krishna Institute of Medical Sciences Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH FORTIS JUBLPHARMA INDGN ONESOURCE PFIZER POLYMEDMcap ₹28,100 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,380.6	1,730.0	2,198.8	4,186.2	4,186.2
+ Capital Work-in-Progress	476.9	600.1	1,213.8	606.2	606.2
+ Goodwill	308.0	308.0	338.6	338.6	338.6
+ Other Intangibles	77.7	64.6	811.1	57.0	57.0
+ Intangibles under Development	0.0	331.2	0.0	0.0	0.0
+ Investments (Equity Method)	0.0	0.0	76.5	0.0	0.0
+ Non-current Investments	0.0	74.4	0.6	0.6	0.6
+ Long-term Loans	0.0	26.0	5.5	13.4	13.4
+ Other Non-current Financial Assets	56.7	92.7	60.1	1,293.6	1,293.6
Non-current Financial Assets	56.7	193.2	66.2	1,307.6	1,307.6
+ Deferred Tax Assets	64.0	31.9	103.7	127.4	127.4
+ Other Non-current Assets	99.8	0.0	230.0	198.3	198.3
Total Non-current Assets	2,463.7	3,259.1	5,038.7	6,821.3	6,821.3
Current Assets
+ Inventories	42.9	49.4	64.0	96.9	96.9
+ Current Investments	67.9	83.0	22.0	15.1	15.1
+ Trade Receivables	252.7	294.4	395.4	554.2	554.2
+ Cash & Cash Equivalents	61.6	46.9	56.0	55.4	55.4
+ Other Bank Balances	4.8	2.1	23.7	19.3	19.3
+ Short-term Loans	0.0	0.0	47.7	72.2	72.2
+ Other Current Financial Assets	36.4	35.8	50.8	67.5	67.5
Current Financial Assets	423.3	462.2	595.6	783.7	783.7
+ Other Current Assets	11.5	35.8	37.7	56.8	56.8
Total Current Assets	477.6	592.9	697.3	937.4	937.4
Total Assets	2,941.3	3,852.0	5,736.0	7,758.7	7,758.7
Equity
+ Equity Share Capital	80.0	80.0	80.0	80.0	80.0
+ Other Equity / Reserves	1,589.5	1,748.3	2,057.8	2,167.4	2,167.4
Equity — Owners of Parent	1,669.5	1,828.4	2,137.8	2,247.4	2,247.4
+ Minority Interest	268.4	264.9	281.0	311.1	311.1
Total Equity	1,938.0	2,093.2	2,418.8	2,558.5	2,558.5
Liabilities
+ Borrowings — Non-current	633.6	1,226.3	2,287.2	2,672.6	2,672.6
+ Other Non-current Financial Liab	0.4	6.5	77.8	1,175.0	1,175.0
Non-current Financial Liabilities	634.0	1,232.8	2,365.0	3,847.6	3,847.6
+ Provisions — Non-current	23.6	27.4	33.5	45.7	45.7
+ Deferred Tax Liabilities	49.2	46.3	46.8	68.0	68.0
+ Other Non-current Liabilities	0.0	0.0	35.7	60.8	60.8
Non-current Liabilities	706.9	1,306.5	2,481.0	3,961.3	3,961.3
+ Borrowings — Current	44.6	129.0	269.5	571.4	571.4
+ Trade Payables	174.3	197.2	269.1	322.8	322.8
+ Other Current Financial Liab	30.5	61.1	215.8	234.1	234.1
Current Financial Liabilities	249.3	387.3	754.4	1,128.3	1,128.3
+ Provisions — Current	14.1	18.6	26.4	32.6	32.6
+ Current Tax Liabilities	0.0	0.0	1.6	0.0	0.0
+ Other Current Liabilities	33.1	46.4	53.8	78.0	78.0
Current Liabilities	296.5	452.3	836.2	1,238.9	1,238.9
Total Liabilities	1,003.3	1,758.8	3,317.2	5,200.2	5,200.2
Total Equity & Liabilities	2,941.3	3,852.0	5,736.0	7,758.7	7,758.7
Assets — additional as-filed lines
+ Current Tax Assets	0.0	45.5	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	15.0	53.4	53.4
+ Dues to Other Creditors — Current	—	—	254.1	269.4	269.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.